0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology

Buy Now

Novel Strategies in the Design and Production of Vaccines (Hardcover, 1996 ed.) Loot Price: R4,688
Discovery Miles 46 880
Novel Strategies in the Design and Production of Vaccines (Hardcover, 1996 ed.): Sara Cohen, Avigdor Shafferman

Novel Strategies in the Design and Production of Vaccines (Hardcover, 1996 ed.)

Sara Cohen, Avigdor Shafferman

Series: Advances in Experimental Medicine and Biology, 397

 (sign in to rate)
Loot Price R4,688 Discovery Miles 46 880 | Repayment Terms: R439 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Vaccination is one of the most efficient and cost effective methods of promoting human health and has been in clinical use for at least 200 years. Nevertheless, infectious diseases continue to constitute a constant threat to the well being of humanity. Common pathogens, once believed to be under control, acquire increased virulence and resistance to drugs, while exotic microorganisms emerged from hidden reservoirs to cause yet incurable diseases in humans. These changes, together with epidemic outbreaks related to political and socio-economic instabilities, increase the needs for the development of new, advanced vaccines. In this volume, devoted to the proceedings of the 39th OHOLO Conference, we present some of the recent strategies for the design and production of novel vaccines. The advent of recombinant DNA technology has stimulated the production of several subunit vaccines. In spite of the obvious advantages to this approach, the limited immuno genicity of many subunit candidates has hindered their development. Strategies to enhance the immunogenicity of subunit vaccines is therefore critical. Several approaches toward this goal, including design of novel adjuvants and delivery systems as well as design of advantageous carriers, are presented here. Among the carriers evaluated here are polypep tides (flagellin, HBV core antigen, J3-galactosidase), attenuated virions (Vaccinia, Sindbis), and nonpathogenic licensed bacteria (Salmonella)."

General

Imprint: Kluwer Academic / Plenum Publishers
Country of origin: United States
Series: Advances in Experimental Medicine and Biology, 397
Release date: 2001
First published: 1996
Editors: Sara Cohen • Avigdor Shafferman
Dimensions: 254 x 178 x 14mm (L x W x T)
Format: Hardcover
Pages: 198
Edition: 1996 ed.
ISBN-13: 978-0-306-45211-6
Categories: Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General
LSN: 0-306-45211-1
Barcode: 9780306452116

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners